Lysophosphatidic acid-stimulated phosphorylation of PKD2 is mediated by PI3K p110β and PKCδ in myoblasts

References

• Karalaki M, Fili S, Philippou A, et al. Muscle regeneration: cellular and molecular events. In Vivo 2009;23:779–96
   PubMed Web of Science ®Google Scholar
• Matheny RW Jr, Nindl BC. Loss of IGF-IEa or IGF-IEb impairs myogenic differentiation. Endocrinology 2011;152:1923–34
   Google Scholar
• Walsh K, Perlman H. Cell cycle exit upon myogenic differentiation. Curr Opin Genet Dev 1997;7:597–602
   PubMed Web of Science ®Google Scholar
• Andres V, Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 1996;132:657–66
   PubMedGoogle Scholar
• Stockdale FE, Holtzer H. DNA synthesis and myogenesis. Exp Cell Res 1961;24:508–20
   PubMed Web of Science ®Google Scholar
• Yaffe D, Feldman M. The formation of hybrid multinucleated muscle fibers from myoblasts of different genetic origin. Dev Biol 1965;11:300–17
   PubMed Web of Science ®Google Scholar
• Lin ME, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat 2010;91:130–8
   PubMed Web of Science ®Google Scholar
• Yoshida S, Fujisawa-Sehara A, Taki T, et al. Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts. J Cell Biol 1996;132:181–93
   PubMedGoogle Scholar
• Xu YJ, Tappia PS, Goyal RK, et al. Mechanisms of the lysophosphatidic acid-induced increase in [Ca(2+)](i) in skeletal muscle cells. J Cell Mol Med 2008;12:942–54
   PubMed Web of Science ®Google Scholar
• Minetti GC, Feige JN, Rosenstiel A, et al. Galphai2 signaling promotes skeletal muscle hypertrophy, myoblast differentiation, and muscle regeneration. Sci Signal 2011;4:ra80
   PubMed Web of Science ®Google Scholar
• Cantrell DA. Phosphoinositide 3-kinase signalling pathways. J Cell Sci 2001;114:1439–45
   PubMed Web of Science ®Google Scholar
• Foukas LC, Shepherd PR. Phosphoinositide 3-kinase: the protein kinase that time forgot. Biochem Soc Trans 2004;32:330–1
   PubMedGoogle Scholar
• Hirsch E, Costa C, Ciraolo E. Phosphoinositide 3-kinases as a common platform for multi-hormone signaling. J Endocrinol 2007;194:243–56
   PubMed Web of Science ®Google Scholar
• Matheny RW, Jr Adamo ML. Effects of PI3K catalytic subunit and Akt isoform deficiency on mTOR and p70S6K activation in myoblasts. Biochem Biophys Res Commun 2009;390:252–7
   PubMedGoogle Scholar
• Foukas LC, Claret M, Pearce W, et al. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 2006;441:366–70
   PubMed Web of Science ®Google Scholar
• Jia S, Liu Z, Zhang S, et al. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 2008;454:776–9
   PubMed Web of Science ®Google Scholar
• Kurosu H, Maehama T, Okada T, et al. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide. J Biol Chem 1997;272:24252–6
   PubMedGoogle Scholar
• Wang QJ. PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol Sci 2006;27:317–23
   PubMed Web of Science ®Google Scholar
• Fu Y, Rubin CS. Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology. EMBO Rep 2011;12:785–96
   PubMedGoogle Scholar
• Guo J, Gertsberg Z, Ozgen N, et al. Protein kinase D isoforms are activated in an agonist-specific manner in cardiomyocytes. J Biol Chem 2011;286:6500–9
   Google Scholar
• Jacamo R, Sinnett-Smith J, Rey O, et al. Sequential protein kinase C (PKC)-dependent and PKC-independent protein kinase D catalytic activation via Gq-coupled receptors: differential regulation of activation loop Ser(744) and Ser(748) phosphorylation. J Biol Chem 2008;283:12877–87
   Google Scholar
• Storz P, Doppler H, Toker A. Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor kappaB. Mol Pharmacol 2004;66:870–9
   PubMed Web of Science ®Google Scholar
• Ellwanger K, Kienzle C, Lutz S, et al. Protein kinase D controls voluntary-running-induced skeletal muscle remodelling. Biochem J 2011;440:324–7
   Google Scholar
• Kim MS, Fielitz J, McAnally J, et al. Protein kinase D1 stimulates MEF2 activity in skeletal muscle and enhances muscle performance. Mol Cell Biol 2008;28:3600–9
   PubMed Web of Science ®Google Scholar
• Kleger A, Loebnitz C, Pusapati GV, et al. Protein kinase D2 is an essential regulator of murine myoblast differentiation. PLoS One 2011;6:e14599
   Google Scholar
• Ellwanger K, Pfizenmaier K, Lutz S, et al. Expression patterns of protein kinase D 3 during mouse development. BMC Dev Biol 2008;8:47
   Google Scholar
• Chen J, Lu G, Wang QJ. Protein kinase C-independent effects of protein kinase D3 in glucose transport in L6 myotubes. Mol Pharmacol 2005;67:152–62
   PubMed Web of Science ®Google Scholar
• Matheny RW, Jr Adamo ML. PI3K p110 alpha and p110 beta have differential effects on Akt activation and protection against oxidative stress-induced apoptosis in myoblasts. Cell Death Differ 2010;17:677–88
   PubMedGoogle Scholar
• Matheny RW Jr, Adamo ML. Role of Akt isoforms in IGF-I-mediated signaling and survival in myoblasts. Biochem Biophys Res Commun 2009;389:117–21
   Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54
   PubMed Web of Science ®Google Scholar
• Rybin VO, Guo J, Steinberg SF. Protein kinase D1 autophosphorylation via distinct mechanisms at Ser744/Ser748 and Ser916. J Biol Chem 2009;284:2332–43
   PubMedGoogle Scholar
• Zugaza JL, Sinnett-Smith J, Van Lint J, et al. Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. EMBO J 1996;15:6220–30
   PubMed Web of Science ®Google Scholar
• Paolucci L, Sinnett-Smith J, Rozengurt E. Lysophosphatidic acid rapidly induces protein kinase D activation through a pertussis toxin-sensitive pathway. Am J Physiol Cell Physiol 2000;278:C33–9
   Google Scholar
• Yuan J, Slice LW, Gu J, et al. Cooperation of Gq, Gi, and G12/13 in protein kinase D activation and phosphorylation induced by lysophosphatidic acid. J Biol Chem 2003;278:4882–91
   Google Scholar
• Roche S, Downward J, Raynal P, et al. A function for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction. Mol Cell Biol 1998;18:7119–29
   PubMed Web of Science ®Google Scholar
• Yart A, Roche S, Wetzker R, et al. A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid. J Biol Chem 2002;277:21167–78
   PubMedGoogle Scholar
• Jackson SP, Schoenwaelder SM, Goncalves I, et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 2005;11:507–14
   PubMed Web of Science ®Google Scholar
• Murga C, Fukuhara S, Gutkind JS. A novel role for phosphatidylinositol 3-kinase beta in signaling from G protein-coupled receptors to Akt. J Biol Chem 2000;275:12069–73
   PubMedGoogle Scholar
• Jean-Baptiste G, Yang Z, Khoury C, et al. Lysophosphatidic acid mediates pleiotropic responses in skeletal muscle cells. Biochem Biophys Res Commun 2005;335:1155–62
   Google Scholar
• Ciraolo E, Iezzi M, Marone R, et al. Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development. Sci Signal 2008;1:ra3
   PubMed Web of Science ®Google Scholar
• Bhavanasi D, Kim S, Goldfinger LE, et al. Protein kinase Cdelta mediates the activation of protein kinase D2 in platelets. Biochem Pharmacol 2011;82:720–7
   Google Scholar
• Doppler H, Storz P. A novel tyrosine phosphorylation site in protein kinase D contributes to oxidative stress-mediated activation. J Biol Chem 2007;282:31873–81
   PubMed Web of Science ®Google Scholar
• Rey O, Yuan J, Young SH, et al. Protein kinase C nu/protein kinase D3 nuclear localization, catalytic activation, and intracellular redistribution in response to G protein-coupled receptor agonists. J Biol Chem 2003;278:23773–85
   PubMedGoogle Scholar
• Song J, Li J, Lulla A, et al. Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-delta pathway activation. Am J Physiol Cell Physiol 2006;290:C1469–76
   Google Scholar
• Waldron RT, Rey O, Iglesias T, et al. Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo. J Biol Chem 2001;276:32606–15
   PubMedGoogle Scholar
• Waldron RT, Rozengurt E. Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. J Biol Chem 2003;278:154–63
   PubMedGoogle Scholar
• Yeh LC, Ma X, Matheny RW, et al. Protein kinase D mediates the synergistic effects of BMP-7 and IGF-I on osteoblastic cell differentiation. Growth Factors 2010;28:318–28
   PubMed Web of Science ®Google Scholar
• Gschwendt M, Dieterich S, Rennecke J, et al. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 1996;392:77–80
   PubMed Web of Science ®Google Scholar
• Gschwendt M, Furstenberger G, Leibersperger H, et al. Lack of an effect of novel inhibitors with high specificity for protein kinase C on the action of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate on mouse skin in vivo. Carcinogenesis 1995;16:107–11
   Google Scholar
• Iijima Y, Laser M, Shiraishi H, et al. c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells. J Biol Chem 2002;277:23065–75
   PubMed Web of Science ®Google Scholar
• Storz P, Doppler H, Toker A. Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling. Mol Cell Biol 2004;24:2614–26
   PubMed Web of Science ®Google Scholar